DPP8 and acute myeloid leukemia: Recent studies have found that small-molecule DPP8/9 inhibitors can induce pyroptosis in human AML cell lines and primary AML samples by activating the caspase-1/GSDMD pathway, which represents a brand-new therapeutic strategy for AML (250).